What is the risk of infection from a tick bite in Spain?
Enfermedades infecciosas y microbiologia clinica (English ed.) · 2025
DOI: 10.1016/j.eimce.2025.09.009 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2025. Verfasst von María Cruz Calvo Reyes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), Dirección General de Salud Pública y Equidad en Salud, Ministerio de Sanidad, Mad…. Hauptthemen laut MEDLINE: Tick Bites, Tick-Borne Diseases. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The development of parameters to estimate the risk of transmission of infections is one of the objectives of entomological surveillance, included in the National Plan for the Prevention, Surveillance and Control of Vector-Borne Diseases. This study aims to assess the utility of the infection prevalence (IP) of Rickettsia spp., Borrelia burgdorferi, and Crimean-Congo haemorrhagic fever virus (CCHFV) in ticks in Spain, as an indicator of the risk of infection from a tick bite and for temporal and geographical comparisons. METHODS: The IP and its 95% confidence interval (95% CI) were calculated for the different microorganism-tick pairs, using data published until April 2024, obtained through a systematic literature review. Studies that included pathogen detection using molecular methods in ticks collected from vegetation (questing ticks) were selected. RESULTS: 581 articles were reviewed, and 20 were selected. The IP of Rickettsia spp. in Dermacentor marginatus was 84.4%, in D. reticulatus 45.9%, and in Rhipicephalus sanguineus 21.2%, with some Rickettsia species causing DEBONEL (R. raoultii and R. slovaca) and MSF-like illness (R. massiliae) being the most frequent. The IP of Borrelia burgdorferi sensu lato in Ixodes ricinus was 5.9%. The IP of CCHFV in Hyalomma spp was 0.3%. CONCLUSIONS: The IP varies for each pathogen-tick pair, from very high for Rickettsia in Dermacentor, to relatively low for Borrelia in Ixodes and CCHFV in Hyalomma. The infection prevalence in ticks can be a useful indicator, along with other factors, for estimating the risk of infection from a tick bite and conducting population risk assessments in Spain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), Dirección General de Salud Pública y Equidad en Salud, Ministerio de Sanidad, Madrid, Spain. Electronic address: mcalvor@sanidad.gob.es.
- Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), Dirección General de Salud Pública y Equidad en Salud, Ministerio de Sanidad, Madrid, Spain.
- Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), Dirección General de Salud Pública y Equidad en Salud, Ministerio de Sanidad, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades I…
Zitieren
APA
Calvo Reyes, M. C., Del Castillo Polo, J. A., García-Expósito, E., Aznar Cano, E., Santos Larrégola, L., Sierra Moros, M. J., & García-San Miguel, L. (2025). What is the risk of infection from a tick bite in Spain?. Enfermedades infecciosas y microbiologia clinica (English ed.). https://doi.org/10.1016/j.eimce.2025.09.009
Vancouver
Calvo Reyes MC, Del Castillo Polo JA, García-Expósito E, Aznar Cano E, Santos Larrégola L, Sierra Moros MJ, et al. What is the risk of infection from a tick bite in Spain?. Enfermedades infecciosas y microbiologia clinica (English ed.). 2025. doi:10.1016/j.eimce.2025.09.009
BibTeX
@article{CalvoReyes2025,
author = {Calvo Reyes, María Cruz and Del Castillo Polo, Juan Antonio and García-Expósito, Esther and Aznar Cano, Esteban and Santos Larrégola, Laura and Sierra Moros, María José and García-San Miguel, Lucía},
title = {What is the risk of infection from a tick bite in Spain?},
journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
year = {2025},
doi = {10.1016/j.eimce.2025.09.009}
}
EUVIMED